2XSmBiT-SARS-CoV-2 S1
(Plasmid
#173430)
-
Purposeprotein expression plasmid of 2XSmBiT-SARS-CoV-2 S1-IgG1 Fc
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 173430 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonephCMV3
- Backbone size w/o insert (bp) 4200
- Total vector size (bp) 7200
-
Vector typeMammalian Expression, Luciferase
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert name2XSmBiT SARS-CoV-2 S1-IgG1 Fc
-
Alt namefusion protein of SmbiT, SARS-CoV-2 Spike S1 region and human IgG1 Fc
-
SpeciesSARS-CoV-2
-
Insert Size (bp)3000
-
Mutationfurin cleavage site RRAR to GSAS
-
GenBank IDMN908947
-
Entrez GeneS (a.k.a. GU280_gp02, spike glycoprotein)
- Promoter CMV
-
Tag
/ Fusion Protein
- human IgG1 Fc (C terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer CMV-F
- 3′ sequencing primer SV40 pA-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
2XSmBiT-SARS-CoV-2 S1 was a gift from David Nemazee (Addgene plasmid # 173430 ; http://n2t.net/addgene:173430 ; RRID:Addgene_173430) -
For your References section:
A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs. Huang D, Tran JT, Peng L, Yang L, Suhandynata RT, Hoffman MA, Zhao F, Song G, He WT, Limbo O, Callaghan S, Landais E, Andrabi R, Sok D, Jardine JG, Burton DR, Voss JE, Fitzgerald RL, Nemazee D. J Immunol. 2021 Jul 1;207(1):344-351. doi: 10.4049/jimmunol.2100155. Epub 2021 Jun 28. 10.4049/jimmunol.2100155 PubMed 34183368